Cargando…
Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix
Autores principales: | Di Giacomo, Anna M., Giacobini, Gianluca, Gandolfo, Claudia, Lofiego, Maria F., Cusi, Maria G., Maio, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339498/ https://www.ncbi.nlm.nih.gov/pubmed/34428684 http://dx.doi.org/10.1016/j.ejca.2021.07.038 |
Ejemplares similares
-
SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines
por: Di Giacomo, Anna M., et al.
Publicado: (2022) -
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID
por: Cusi, Maria Grazia, et al.
Publicado: (2023) -
Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy
por: Fazio, Carolina, et al.
Publicado: (2018) -
Circulating Levels of PD-L1 in Mesothelioma Patients from the NIBIT-MESO-1 Study: Correlation with Survival
por: Chiarucci, Carla, et al.
Publicado: (2020) -
Immune response to the severe acute respiratory syndrome coronavirus 2 vaccines: Is it sustained in the diabetes population?
por: Rouka, Erasmia, et al.
Publicado: (2022)